Inclusion Criteria:  Willing and able to provide informed consent and participate in the required study visit  Subjects determined to have signs and symptoms of evaporative Dry Eye disease due to MGD, defined by the following:  OSDI score >13 and NITBUT <= 10sec  Exclusion Criteria:  No use of warm compresses, intense pulsed light therapy or other lid warming treatment in the past 6 Months Patients with greater 75% meibomian gland loss Presence of ocular pathology or systemic conditions other than previously diagnosed moderate or severe chronic dry eye and/or Sjogren's syndrome, that in the investigator's judgment may affect the testing for, or diagnosis of, dry eye if present Use of prescribed ocular topical medication (e.g., anti-hypertensive, steroid, Cyclosporin A, antibiotic) within the last 24 hours Artificial tear usage within 2 hours prior to study testing Other invasive ocular diagnostic testing within 2 hours prior to study testing Eye makeup present on the eye lid within 10 minutes prior to study testing